Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Julphar
US Army
Covington
Chinese Patent Office
UBS
QuintilesIMS
Cipla
McKesson

Generated: April 21, 2018

DrugPatentWatch Database Preview

Nuvo Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NUVO PHARMS INC, and when can generic versions of NUVO PHARMS INC drugs launch?

NUVO PHARMS INC has one approved drug.

There are four US patents protecting NUVO PHARMS INC drugs.

Summary for Nuvo Pharms Inc
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Nuvo Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nuvo Pharms Inc PENNSAID diclofenac sodium SOLUTION;TOPICAL 020947-001 Nov 4, 2009 DISCN Yes No 8,546,450 ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharms Inc PENNSAID diclofenac sodium SOLUTION;TOPICAL 020947-001 Nov 4, 2009 DISCN Yes No 8,618,164 ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharms Inc PENNSAID diclofenac sodium SOLUTION;TOPICAL 020947-001 Nov 4, 2009 DISCN Yes No 8,741,956 ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharms Inc PENNSAID diclofenac sodium SOLUTION;TOPICAL 020947-001 Nov 4, 2009 DISCN Yes No 8,217,078 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for NUVO PHARMS INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Solution 1.5% ➤ Subscribe 2012-07-11
➤ Subscribe Topical Solution 2.0% ➤ Subscribe 2014-06-03

Non-Orange Book US Patents for Nuvo Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,375,412 Treatment of pain with topical diclofenac ➤ Try a Free Trial
9,415,029 Treatment of pain with topical diclofenac ➤ Try a Free Trial
9,132,110 Treatment of pain with topical diclofenac ➤ Try a Free Trial
9,370,501 Treatment of pain with topical diclofenac ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
Covington
Federal Trade Commission
Moodys
Citi
Baxter
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.